06/03/2022 In its recent USA 2022 legal rankings edition, Chambers & Partners again recognized RMMS with a strong ‘Band 3’ ranking in the Chambers Illinois – Intellectual Property guide as well as a new ‘Band 5’ ranking in the Chambers Nationwide – Life Sciences guide.
Additionally, Chambers again recognized RMMS founding partner William Rakoczy in the Illinois – Intellectual Property individual rankings (‘Band 1’) as well as in the Nationwide Life Sciences: IP/Patent Litigation rankings (‘Band 3’). He joins just thirteen other individual practitioners selected for recognition as ‘Ranked Lawyers’ in the Nationwide Life Sciences: IP/Patent Litigation practice area.
In connection with the firm’s work, Chambers USA recognizes RMMS as a:
Boutique firm much admired for its artful representation of generic pharmaceutical manufacturers in complex ANDA litigation. Other areas of strength include freedom-to-operate searches and licensing and collaboration agreements. Increasing bench strength sees it offer wider expertise beyond its traditional generics client base, bolstering its handling of brand mandates.
Chambers USA added:
Rakoczy Molino Mazzochi Siwik LLP has a highly-regarded Chicago-based life sciences practice. The team is known for its deep litigation experience assisting clients with patent validity, Hatch-Waxman, and IP infringement disputes. The team is further able to support clients on commercial matters including patent licensing and collaboration agreements.
As part of its research, Chambers interviews lawyers and clients. One client praised the RMMS team, noting that ‘[t]he RMMS team always keeps its client’s end goal in mind and secures the best outcome for them.’
Chambers USA rankings are based on independent research and in-depth client and attorney interviews, which assess a firm’s legal knowledge, experience, and ability.
About RMMS Headquartered in Chicago, RMMS is a full-service litigation and intellectual property law firm with over 30 attorneys devoted exclusively to the life sciences industry, including specialty practice in the field of patent and regulatory counseling and litigation under the Hatch-Waxman Act, the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), and the Biologics Price Competition and Innovation Act (BPCIA).